Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Pankaj Pandey, Kuldeep K. Roy & Robert J. Doerksen. (2020) Negative allosteric modulators of cannabinoid receptor 2: protein modeling, binding site identification and molecular dynamics simulations in the presence of an orthosteric agonist. Journal of Biomolecular Structure and Dynamics 38:1, pages 32-47.
Read now
Read now
Articles from other publishers (28)
Miroslav Kosar, Roman C. Sarott, David A. SykesAlexander E. G. Viray, Rosa Maria Vitale, Nataša Tomašević, Xiaoting Li, Rudolf L. Z. Ganzoni, Bilal Kicin, Lisa Reichert, Kacper J. Patej, Uxía Gómez-Bouzó, Wolfgang Guba, Peter J. McCormickTian Hua, Christian W. Gruber, Dmitry B. Veprintsev, James A. Frank, Uwe Grether & Erick M. Carreira. (2024) Flipping the GPCR Switch: Structure-Based Development of Selective Cannabinoid Receptor 2 Inverse Agonists. ACS Central Science.
Crossref
Crossref
Jiayi Yuan, Bo Yang, Guanyu Hou, Xiang-Qun Xie & Zhiwei Feng. (2023) Targeting the endocannabinoid system: Structural determinants and molecular mechanism of allosteric modulation. Drug Discovery Today 28:7, pages 103615.
Crossref
Crossref
Claudia Mugnaini, Magdalena Kostrzewa, Marta Casini, Poulami Kumar, Valeria Catallo, Marco Allarà, Laura Guastaferro, Antonella Brizzi, Marco Paolino, Andrea Tafi, Christelos Kapatais, Gianluca Giorgi, Federica Vacondio, Marco Mor, Federico Corelli & Alessia Ligresti. (2023) Systematic Modification of the Substitution Pattern of the 7-Hydroxy-5-oxopyrazolo[4,3-b]pyridine-6-carboxamide Scaffold Enabled the Discovery of New Ligands with High Affinity and Selectivity for the Cannabinoid Type 2 Receptor. Molecules 28:13, pages 4958.
Crossref
Crossref
Maha Hameed, Sakshi Prasad, Esha Jain, Bekir Nihat Dogrul, Ahmad Al-Oleimat, Bidushi Pokhrel, Selia Chowdhury, Edzel Lorraine Co, Saloni Mitra, Jonathan Quinonez, Samir Ruxmohan & Joel Stein. (2023) Medical Cannabis for Chronic Nonmalignant Pain Management. Current Pain and Headache Reports 27:4, pages 57-63.
Crossref
Crossref
Bismarck Rezende, Allan Kardec Nogueira Alencar, Graziele Freitas de Bem, Fabrícia Lima Fontes-Dantas & Guilherme Carneiro Montes. (2023) Endocannabinoid System: Chemical Characteristics and Biological Activity. Pharmaceuticals 16:2, pages 148.
Crossref
Crossref
Amelia Seifalian, Julian Kenyon & Vik Khullar. (2022) Dysmenorrhoea: Can Medicinal Cannabis Bring New Hope for a Collective Group of Women Suffering in Pain, Globally?. International Journal of Molecular Sciences 23:24, pages 16201.
Crossref
Crossref
Islam Shehata, Ahmed Hashim, Ahmed Saad Elsaeidy, Anagha Nair, Ivan Urits, Omar Viswanath, Alan D. Kaye & Marian Habib. (2022) Cannabinoids and Their Role in Chronic Pain Treatment: Current Concepts and a Comprehensive Review. Health Psychology Research 10:4.
Crossref
Crossref
Simran Kaur, Nikita Sharma & Arpita Roy. (2022) Role of Cannabinoids in Various Diseases: A Review. Current Pharmaceutical Biotechnology 23:11, pages 1346-1358.
Crossref
Crossref
Zak M. Whiting, Jiazhen Yin, Sara M. de la Harpe, Andrea J. Vernall & Natasha L. Grimsey. (2022) Developing the Cannabinoid Receptor 2 (CB2) pharmacopoeia: past, present, and future. Trends in Pharmacological Sciences 43:9, pages 754-771.
Crossref
Crossref
Yongmin Liu, Min Jia, Caihua Wu, Hong Zhang, Chao Chen, Wenqiang Ge, Kexing Wan, Yuye Lan, Shiya Liu, Yuanheng Li, Mengyue Fang, Jiexi He, Hui-Lin Pan, Jun-Qiang Si & Man Li. (2022) Transcriptomic Profiling in Mice With CB1 receptor Deletion in Primary Sensory Neurons Suggests New Analgesic Targets for Neuropathic Pain. Frontiers in Pharmacology 12.
Crossref
Crossref
Briana Hempel & Zheng-Xiong Xi. 2022. Behavioral Pharmacology of Drug Abuse: Current Status. Behavioral Pharmacology of Drug Abuse: Current Status
275
333
.
Martin F. Casey & Alex F. Manini. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
415
446
.
Xiaoyu Ji, Yang Zeng & Jie Wu. (2021) The CB2 Receptor as a Novel Therapeutic Target for Epilepsy Treatment. International Journal of Molecular Sciences 22:16, pages 8961.
Crossref
Crossref
Hebaallah Mamdouh Hashiesh, Charu Sharma, Sameer N. Goyal, Niraj Kumar Jha & Shreesh Ojha. (2021) Pharmacological Properties, Therapeutic Potential and Molecular Mechanisms of JWH133, a CB2 Receptor-Selective Agonist. Frontiers in Pharmacology 12.
Crossref
Crossref
Angela Ramírez‐López, Antoni Pastor, Rafael de la Torre, Carmen La Porta, Andrés Ozaita, David Cabañero & Rafael Maldonado. (2021) Role of the endocannabinoid system in a mouse model of Fragile X undergoing neuropathic pain. European Journal of Pain 25:6, pages 1316-1328.
Crossref
Crossref
Yane Costa Chaves, Karina Genaro, José Alexandre Crippa, Joice Maria da Cunha & Janaína Menezes Zanoveli. (2021) Cannabidiol induces antidepressant and anxiolytic‐like effects in experimental type-1 diabetic animals by multiple sites of action. Metabolic Brain Disease 36:4, pages 639-652.
Crossref
Crossref
Sameek Singh, Ian Liddle, Christa Macdonald, Joel D. A. Tyndall, Michelle Glass & Andrea J. Vernall. (2020) Development of Chromenopyrazole-Based Selective Cannabinoid 2 Receptor Agonists. Australian Journal of Chemistry 74:6, pages 433-442.
Crossref
Crossref
Adarsh Thomas Anthony, Shermeen Rahmat, Prerna Sangle, Osama Sandhu & Safeera Khan. (2020) Cannabinoid Receptors and Their Relationship With Chronic Pain: A Narrative Review. Cureus.
Crossref
Crossref
David Cabañero, Angela Ramírez-López, Eva Drews, Anne Schmöle, David M Otte, Agnieszka Wawrzczak-Bargiela, Hector Huerga Encabo, Sami Kummer, Antonio Ferrer-Montiel, Ryszard Przewlocki, Andreas Zimmer & Rafael Maldonado. (2020) Protective role of neuronal and lymphoid cannabinoid CB2 receptors in neuropathic pain. eLife 9.
Crossref
Crossref
K.H. Binda, C.C. Real, A.F.F. Ferreira, L.R. Britto & M. Chacur. (2020) Antinociceptive effects of treadmill exercise in a rat model of Parkinson's disease: The role of cannabinoid and opioid receptors. Brain Research 1727, pages 146521.
Crossref
Crossref
Vivek S. Kumawat & Ginpreet Kaur. (2019) Therapeutic potential of cannabinoid receptor 2 in the treatment of diabetes mellitus and its complications. European Journal of Pharmacology 862, pages 172628.
Crossref
Crossref
Sameek Singh, Caitlin R. M. Oyagawa, Christa Macdonald, Natasha L. Grimsey, Michelle Glass & Andrea J. Vernall. (2019) Chromenopyrazole-based High Affinity, Selective Fluorescent Ligands for Cannabinoid Type 2 Receptor. ACS Medicinal Chemistry Letters 10:2, pages 209-214.
Crossref
Crossref
Pankaj Pandey, Kuldeep Roy, Haining Liu, Guoyi Ma, Sara Pettaway, Walid Alsharif, Rama Gadepalli, John Rimoldi, Christopher McCurdy, Stephen Cutler & Robert Doerksen. (2018) Structure-Based Identification of Potent Natural Product Chemotypes as Cannabinoid Receptor 1 Inverse Agonists. Molecules 23:10, pages 2630.
Crossref
Crossref
Natascia Bruni, Carlo Della Pepa, Simonetta Oliaro-Bosso, Enrica Pessione, Daniela Gastaldi & Franco Dosio. (2018) Cannabinoid Delivery Systems for Pain and Inflammation Treatment. Molecules 23:10, pages 2478.
Crossref
Crossref
Chihiro Nozaki, Elisa Nent, Andras Bilkei-Gorzo & Andreas Zimmer. (2018) Involvement of leptin signaling in the development of cannabinoid CB2 receptor-dependent mirror image pain. Scientific Reports 8:1.
Crossref
Crossref
M.A. Fitzcharles & E. Eisenberg. (2018) Medical cannabis: A forward vision for the clinician. European Journal of Pain 22:3, pages 485-491.
Crossref
Crossref
Qing-Rong Liu, Ana Canseco-Alba, Hai-Ying Zhang, Patricia Tagliaferro, Monika Chung, Eugene Dennis, Branden Sanabria, Norman Schanz, Joao Carlos Escosteguy-Neto, Hiroki Ishiguro, Zhicheng Lin, Susan Sgro, Claire M. Leonard, Jair Guilherme Santos-Junior, Eliot L. Gardner, Josephine M. Egan, Jeung Woon Lee, Zheng-Xiong Xi & Emmanuel S. Onaivi. (2017) Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference. Scientific Reports 7:1.
Crossref
Crossref
Nebojsa Nick KnezevicAjay YekkiralaTony L. Yaksh. (2017) Basic/Translational Development of Forthcoming Opioid- and Nonopioid-Targeted Pain Therapeutics. Anesthesia & Analgesia 125:5, pages 1714-1732.
Crossref
Crossref